Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.18 Til Enterprise Value: 1.58 Til PE Ratio: 36.22 PB Ratio: 20.20 GF Score: 92/100

Amgen Inc WCLC Data Highlights Investor Call Transcript

Jan 30, 2021 / 01:00AM GMT
Operator

My name is Cindy, and I'll be your conference facilitator today for Amgen's conference call from the World Conference on Lung Cancer. (Operator Instructions) And I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thank you, Cindy, and good evening, everybody. So let me begin by thanking you for taking the time on a Friday evening to participate in our session. My initial logic was to conduct this session as close as possible to the presentation of our sotorasib Phase II data in the scientific session at the World Lung Conference. But as you know, we ended up putting out a press release yesterday containing most of the data as there was a media leak of embargoed material. Regardless, we are delighted that you can join us.

We are pleased with the progress we have made with this program on several dimensions: the speed with which we have gone from first-in-human to NDA submission; quality of the data having undertaken an intent-to-treat analysis and central

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot